Submission Details
| 510(k) Number | K010550 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 26, 2001 |
| Decision Date | April 24, 2001 |
| Days to Decision | 57 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Summary PDF |
K010550 is an FDA 510(k) clearance for the VIDAS TOTAL PROSTATE SPECIFIC ANTIGEN (TPSA), MODEL 30 428, a Prostate-specific Antigen (psa) For Management Of Prostate Cancers (Class II — Special Controls, product code LTJ), submitted by bioMerieux, Inc. (Hazelwood, US). The FDA issued a Cleared decision on April 24, 2001, 57 days after receiving the submission on February 26, 2001. This device falls under the Immunology review panel. Regulated under 21 CFR 866.6010.
| 510(k) Number | K010550 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 26, 2001 |
| Decision Date | April 24, 2001 |
| Days to Decision | 57 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Summary PDF |
| Product Code | LTJ — Prostate-specific Antigen (psa) For Management Of Prostate Cancers |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.6010 |